Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Trial and error in clinical studies: lessons from ATAMS.
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management.
The dual task-cost of standing balance affects quality of life in mildly disabled MS people.
Sex-related differences in atrophy and lesion load in multiple sclerosis patients.
The effect of exercise on depressive symptoms in adults with neurological disorders: A systematic review and meta-analysis.
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis.
A JOINT FRAMEWORK FOR 4D SEGMENTATION AND ESTIMATION OF SMOOTH TEMPORAL APPEARANCE CHANGES.
Meta-Analysis of the Correlation Between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis.
Quantitative assessment of finger motor impairment in multiple sclerosis.
Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.
Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.
Neurologist ambulatory care, health care utilization, and costs in a large commercial dataset.
Immunogenicity and other problems associated with the use of biopharmaceuticals.
Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis.
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings.
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.
The Efficacy of Primidone in Reducing Severe Cerebellar Tremors in Patients With Multiple Sclerosis.
Use of botulinum toxin for genitourinary conditions: What is the evidence?
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
Pages
« first
‹ previous
…
389
390
391
392
393
394
395
396
397
…
next ›
last »